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別 紙 様 式 3 (課程博士 •論文博士共用)
論 文 内 容 要 旨
0整 理 番 号 838 (ふりがな）氏  名 もはまつど ふすに びん あ一まと あみんMohammad Khusni Bin Ahmat Amin
学位論文題目
Epithelial membrane protein 1 promotes tumor metastasis by enhancing 
cell migration via copine-III and Racl.
(Epithelial membrane protein 1 ががん転移を促進するのは、copine-III 
によるR a c l活性化で細胞遊走が亢進するためである）
目 的 (Purpose)
Cancer metastasis is the worst-case phenomenon in the cancer progression and 
responsible for approximately 90% of cancer-related death. The interaction between cancer 
cells and other types o f cells in the tumor microenvironment is the principal key that 
regulates cancer metastasis. However, the molecular mechanism by which the cell-to-cell 
contact-mediated tumor microenvironment is involved in the regulation remains to be 
elucidated. The purpose o f this study is to unveil the regulatory mechanism by focusing on 
the intercellular physical contact between prostate cancer cells and stromal cells.
方 法 (Method)
The co-culture system between human prostate cancer LNCaP cells and human prostate 
stromal (PrS) cells was developed to mimic the tumor microenvironment. The 
differentially expressed genes were analyzed by the Affymetrix DNA microarray and 
compared between LNCaP cells co-cultured with PrS cells and cultured alone. Stable 
clones of cancer cells overexpressing epithelial membrane protein 1 (EMP1) were 
established. EMP1-LNCaP cells or parental LNCaP cells (1 x 107 cells) were implanted 
into the prostate gland o f male BALB/c nude mice (7 weeks old) via orthotopic injection 
and administrated for 6 weeks. The histopathological analysis was carried out to examine 
the tumor formation in the prostate and the metastasis in the lymph nodes and lung. The 
migratory activity was investigated using the Boyden chamber and invasion assay. To 
identify the binding partner o f EMP1, the tandem mass spectrometry was perform ed,丄'he 
immunoprecipitation and immunofluorescent microscope assays were conducted to 
examine the interaction between EMP1， copine-III, Src and Vav2. The pull-down assay 
was performed to evaluate the Racl activity. Human prostate cancer samples were used to 
analyze the expression level ofE M P l.
結 果 (Results)
As the result from bio informatics analysis after the DNA micro array assay, the
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expression level o f EMP1 was significantly up-regulated in LNCaP cells co-cultured with 
PrS cells, compared with LNCaP cells cultured alone. When EMP1-LNCaP cells were 
orthotopically implanted into the prostate gland o f nude mice, the lymph nodes and lung 
metastases occurred, which was not observed by the implantation of parental LNCaP cells. 
The size o f the tumors grown in the prostate was similar between the two types o f LNCaP 
cells. EMP1 has four times membrane passing structure and mainly localizes on the plasma 
membrane. To explore which molecules contribute to the EMP1-induced pro-metastatic 
property in cancer cells, the intracellular binding partner o f EMP1 was examined by the 
tandem mass spectrometry, resulting in the identification o f copine-III. The migration and 
invasion assays revealed that EMP1 promoted cell migratory activity in not only prostate 
cancer cells but also breast and colon cancer cells. The activation o f R acl, which plays an 
important role in cell migration, was induced by EMP1. The activation required the 
EM Pl-copine-III binding. Next, it was investigated how Racl was activated downstream 
of the EM Pl-copine-III complex. The complex phosphorylated and activated Src， and 
then, activated Src induced the activation o f Vav2, a guanine nucleotide exchange factor 
for R ac l， leading to the enhanced cancer cell migration and metastasis. As clinical 
implications, increased expression and invasive front localization of EMP1 were observed 
in the samples from the patients with higher Gleason scores of prostate cancer.
考 察 (Discussion)
This study has shown the pro-metastasis of a surface membrane protein EMP1 in both 
in vitro and in vivo models. The novel discovery at the molecular level in this study was 
that EMP1 directly interacted with copine-III in the cytoplasmic region, and that the 
interaction induced the activation o f the Src-Vav2-Racl axis, which suggests the 
underlying mechanism in the EMP1-enhanced metastasis. The finding is supported by the 
evidence that the expression of copine-III was significantly higher in metastatic prostate 
cancer and ovarian endometrioid adenocarcinoma in the microarray data sets from the 
ONCOMINE database. In addition, genome-wide association analysis showed that an SNP 
in the copine-III gene is associated with susceptibility to prostate cancer. With respect to 
clinical implications, the development of pharmacological inhibitors or inhibitory 
antibodies against EMP1 may have a positive insight in anti-cancer therapy, because the 
high expression o f EMP1 was observed in several types o f pro-metastatic cancers. This 
might be a challenging future research project.
結 論 (Conclusion)
This study demonstrates the potential mechanism ofE M P l in cancer metastasis. EMP1 
and its binding partner copine-III facilitate the activation of Src, Vav2, and R acl, resulting 
in enhanced cancer cell migration and metastasis.
別 紙 様 式 8 (課程博士 •論文博士共用)
学位論文審査の結果の要旨
整理番号 8 3 8 氏 名 Mohammad Khusni Bin Ahmat Amin
論文審査委員
(学位論文審査の結果の要旨）※明朝体1 1 ポイント、 6 0 0 字以内で作成のこと
癌細胞の周辺組織への遊走や遠隔臓器への転移には、ストローマ細胞との相互作用が重要 
であると考えられているが、それに関わる分子やメカニズムは明らかではない。
本研究では、前立腺癌細胞の遊走や転移に関わる因子として、E M P 1という膜タンパク質 
と、その細胞内ドメインに結合するCopine-inを同定し、E M P 1の発現によって遊走活性が 
上昇する分子メカニズムについて検討を行い、以下の点を明らかにした。
1 ） ストローマ細胞との共培養によって、前立腺癌細胞株L N C aP細胞で発現が上昇する遺 
伝子としてE M P 1を同定した。
2 ） E M P 1を過剰発現したL N C aP細胞は遊走活性が上昇し、ヌードマウスに移植すると転 
移能を示した。
3 ) E M P 1の細胞内ドメインに結合する因子としてCopine-IHを同定し、Copine-IHをノック 
ダウンするとE M P 1の過剰発現による遊走活性が低下することを示した。
4 ） E M P 1の過剰発現により、Src、Vav2、R a c l経路が Copine-mに依存して活性化され、 
遊走活性が上昇した。
5 ） 前立腺癌組織において、侵襲性の高い癌サンプルでE M P 1が発現上昇していた。
本論文は、癌細胞の遊走活性や転移能におけるE M P 1と Copine-mの機能について新しい 
知見を与えたものであり、最終試験として論文内容に関連した試問を受け合格したので、博 
士 （医学）の学位論文に値するものと認められた。
(総字数 5 9 2 字）
(平成31年 1 月 3 0 日）
